Correction to: HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History (Journal of Neuroimmune Pharmacology, (2020), 15, 4, (715-728), 10.1007/s11481-020-09928-5)

Jessica M. Illenberger, Steven B. Harrod, Charles F. Mactutus, Kristen A. McLaurin, Asha Kallianpur, Rosemarie M. Booze

Research output: Contribution to journalComment/debate

Abstract

Corrected references: Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop- Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15(3): 257–274 Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011) Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychologal performance. J Neurovirol 17(1):26–40 Corrected sentence in Interactions between the Effects of Drug Use and HIV-1 Infection Leads to Accelerated Disease Progression: “White matter damage (Tang et al. 2015; Alakkas et al. 2019), mitochondrial dysfunction (Buch et al. 2011), and iron dysregulation (Drakesmith et al. 2005; Ersche et al. 2017) occur with cocaine use and have also been associated with HIV infection and HAND; these processes may therefore be promising targets for treatment development”.

Original languageEnglish
Pages (from-to)876
Number of pages1
JournalJournal of NeuroImmune Pharmacology
Volume15
Issue number4
DOIs
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Funding

FundersFunder number
National Institutes of Health (NIH)

    ASJC Scopus subject areas

    • Neuroscience (miscellaneous)
    • Immunology and Allergy
    • Immunology
    • Pharmacology

    Fingerprint

    Dive into the research topics of 'Correction to: HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History (Journal of Neuroimmune Pharmacology, (2020), 15, 4, (715-728), 10.1007/s11481-020-09928-5)'. Together they form a unique fingerprint.

    Cite this